Next Article in Journal
Polyunsaturated Fatty Acids and Risk of Ischemic Stroke
Next Article in Special Issue
Efficacy of Polygonatum sibiricum on Mild Insomnia: A Randomized Placebo-Controlled Trial
Previous Article in Journal
The Acute Effect of Various Doses of Caffeine on Power Output and Velocity during the Bench Press Exercise among Athletes Habitually Using Caffeine
Previous Article in Special Issue
Bridging the Reciprocal Gap between Sleep and Fruit and Vegetable Consumption: A Review of the Evidence, Potential Mechanisms, Implications, and Directions for Future Work
An updated version is available. Download PDF
Open AccessArticle

A Double-Blind, Randomized, Placebo-Controlled Crossover Clinical Study of the Effects of Alpha-s1 Casein Hydrolysate on Sleep Disturbance

1
Sleep Center, Ewha Womans University Mokdong Hospital, Seoul 07985, Korea
2
Departments of Neurology, Ewha Womans University School of Medicine and Ewha Medical Research Institute, Seoul 07804, Korea
3
Departments of Medical Science, Ewha Womans University School of Medicine and Ewha Medical Research Institute, Seoul 07804, Korea
4
INGREDIA Co., Ltd., CEDEX, 62000 Arras, France
5
Departments of Molecular Medicine, Ewha Womans University School of Medicine and Ewha Medical Research Institute, Seoul 07804, Korea
*
Author to whom correspondence should be addressed.
Director, Epilepsy and Sleep Center, Ewha Womans University Mokdong Hospital, 1071, Anyangcheon-ro, Yangcheon-gu, Seoul, 07985, Korea.
Professor, Department of Neurology, Ewha Womans University School of Medicine and Ewha Medical Research Institute, 25, Magokdong-ro 2-gil, Gangseo-gu, Seoul 07804, Korea.
Nutrients 2019, 11(7), 1466; https://doi.org/10.3390/nu11071466
Received: 17 May 2019 / Revised: 19 June 2019 / Accepted: 23 June 2019 / Published: 27 June 2019
(This article belongs to the Special Issue Sleep, Nutrition, and Human Health)
This study evaluated the effects of alpha-s1 casein hydrolysate (ACH; Lactium®) on the subjective and objective sleep profiles of a community-based sample of Koreans with poor sleep quality. We performed a double-blind, randomized crossover trial with 48 participants (49.0 ± 1.7 years old, 65% female) who exhibited a mild to moderate degree of sleep disturbance. Either ACH or placebo was administered for the initial four weeks, and the counterpart was administered in precisely the same manner after a four-week washout period. Sleep disturbance scales, daytime functioning, and psychiatric aspects showed a similar tendency to improve during both ACH and placebo phases without significant group differences. Overall perceived sleep profiles in sleep diaries were significantly improved during the ACH phase, represented by increased total sleep time and sleep efficiency (SE), as well as decreased sleep latency and wake after sleep onset (WASO). Interestingly, actigraphy demonstrated significantly increased SE after continuous use of ACH for four weeks, clearly more improved when compared to two weeks of use. The polysomnography measures showed a similar tendency without statistically significant group differences. Our findings suggest that refined ACH was well tolerated and could improve sleep quality, with possible cumulative beneficial effects with long-term administration. View Full-Text
Keywords: alpha-s1 casein hydrolysate; Lactium®; nutritional supplements; clinical trial; sleep disturbance; insomnia; sleep quality alpha-s1 casein hydrolysate; Lactium®; nutritional supplements; clinical trial; sleep disturbance; insomnia; sleep quality
Show Figures

Figure 1

MDPI and ACS Style

Kim, H.J.; Kim, J.; Lee, S.; Kim, B.; Kwon, E.; Lee, J.E.; Chun, M.Y.; Lee, C.Y.; Boulier, A.; Oh, S.; Lee, H.W. A Double-Blind, Randomized, Placebo-Controlled Crossover Clinical Study of the Effects of Alpha-s1 Casein Hydrolysate on Sleep Disturbance. Nutrients 2019, 11, 1466.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map

1
Back to TopTop